1) Yi pulp granules
益髓颗粒剂
2) Yisui Shengxue Granule
益髓生血颗粒
1.
Effect of Yisui Shengxue Granule on Thalassemia;
中药益髓生血颗粒治疗地中海贫血的临床研究
2.
Clinical Observation on Effects of Yisui Shengxue Granule in Treating 156 Patients with β-thalassemia;
益髓生血颗粒治疗β-地中海贫血156例临床观察
3.
Clinical Effect of Yisui Shengxue Granule on β-Thalassemia Major
益髓生血颗粒治疗重型β珠蛋白生成障碍性贫血的疗效
3) Yisui Shengxue granules
益髓生血颗粒
1.
Effect on expression of mice alpha-hemoglobin stabilizing protein in different developmental stages treated with Yisui Shengxue granules;
益髓生血颗粒对不同发育阶段小鼠α-血红蛋白稳定蛋白表达的影响
2.
Effects of Yisui Shengxue Granules on expressions of alpha-hemoglobin stabilizing protein and erythroid transcription factor GATA-1 mRNAs in bone marrow of patients with β-thalassemia;
中药益髓生血颗粒对β地中海贫血患者骨髓α血红蛋白稳定蛋白及红系转录因子GATA-1基因表达的影响
4) Yi-gan Granules
益苷颗粒剂
1.
The Effect of Yi-gan Granules on the Immunity Function of Mice;
益苷颗粒剂对小鼠免疫功能的影响
5) Yi Shen Granule
益肾颗粒剂
1.
The Clinical Effects and Significance of Serum sFas/sFasL Study on Treatment of Lupus Nephritis by Yi Shen Granule;
益肾颗粒剂对肝肾阴虚型狼疮肾炎患者血清sFas/sFasL水平的影响
6) Busuishengxue granule
补髓生血颗粒剂
1.
Objective: This article discussed the clinical effective of Busuishengxue granule to chronic aplastic anemia (CAA) patients, and observed the difference in expression level of myelo-cytokine c-kit/CD117, c-Met/HGF and CD34~+ cell in CAA patients before and after treatment.
目的:探讨补髓生血颗粒剂对慢性再生障碍性贫血(以下简称为CAA)患者的临床疗效及治疗前后骨髓c-kit/CD117、HGF/c-met及CD34~+细胞表达水平的影响。
2.
Objective: This article discussed the clinical effect of Busuishengxue granule to chronic aplastic anemia (CAA) patients, and observed the different expression level of serum cytokine Interleukin-6 (IL-6) in CAA patients before and after treatment.
目的:探讨补髓生血颗粒剂对慢性再生障碍性贫血(以下简称为CAA)患者的临床疗效及其对治疗前后血清IL-6表达水平的影响,进一步揭示CAA发病机制及补肾中药治疗CAA的作用机理。
补充资料：干流动剂、水悬性颗粒剂
分子式：
CAS号：
性质：又称干流动剂、水悬性颗粒剂。入水后，自动崩解，分散成悬浮液。它是在可湿性粉剂和悬浮剂的基础上发展起来的新剂型，它具有分散性好，悬浮率高、稳定性好、使用方便等特点，避开了可湿性粉剂产生粉尘，悬浮剂包装运输不便，贮藏易产生沉淀、结块、流动性差、粘壁等缺点。生产方法有喷雾造粒、悬式造粒、挤压造粒、高强度混合造粒、流化床造粒等。
CAS号：
性质：又称干流动剂、水悬性颗粒剂。入水后，自动崩解，分散成悬浮液。它是在可湿性粉剂和悬浮剂的基础上发展起来的新剂型，它具有分散性好，悬浮率高、稳定性好、使用方便等特点，避开了可湿性粉剂产生粉尘，悬浮剂包装运输不便，贮藏易产生沉淀、结块、流动性差、粘壁等缺点。生产方法有喷雾造粒、悬式造粒、挤压造粒、高强度混合造粒、流化床造粒等。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条